Superscript Systems Ltd

Superscript Systems Ltd was hired by SuiCura, an AI-powered cosmetics marketplace, to develop their core concept. The company was selected for their high ratings, value for cost, and alignment with SuiCura's values. A team of 2-5 employees from Superscript Systems Ltd was assigned to the project. The key deliverable was the development of an AI-powered personalized cosmetics marketplace. The company was referred to SuiCura and was chosen due to their high ratings, budget-friendly pricing, and value for cost. The project was successfully completed, meeting the client's expectations and bringing SuiCura's core concept to life.

For Titlepool, a technology design company for the film industry, Superscript Systems Ltd was hired to build custom software that incorporated both AI and blockchain. The project involved development, design, and research for a startup product, with ongoing addition of new modules and elements. Superscript Systems Ltd built both the front and backend of the platform, working well with an external designer. They integrated Stripe as the payment processor, creating an intuitive flow across the platform. The project is ongoing and has so far cost around $800,000. The founder of Superscript Systems Ltd was personally involved in the project, showing enthusiasm and passion.

Oxitone Medical, a medical device manufacturer and digital health platform developer, hired Superscript Systems Ltd to develop a mobile app and platform for fetus monitoring. The scope of work included the delivery of a fully integrated, machine learning-powered reporting system and mobile application. The software enhances Oxitone's medical device by providing advanced analytics, automated reporting, and a seamless patient experience. The engagement also includes ongoing support. Superscript Systems Ltd was chosen for the project due to their high ratings, budget-friendly pricing, great culture fit, and value for cost. The project was successfully completed, enhancing the functionality and user experience of Oxitone's medical device.